Page 2 - Appia Cells Utilized News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Appia cells utilized. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Appia Cells Utilized Today - Breaking & Trending Today

Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board


Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
Proceeds will be used to progress stem cell derived CAR-engineered invariant natural killer T cells (CAR-iNKT) to the clinic in hematological and solid tumor indications
News provided by
Share this article
Share this article
LOS ANGELES, May 11, 2021 /PRNewswire/ Appia Bio, Inc., an early stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer patients, today announced its launch from stealth backed by $52 million Series A financing led by 8VC. Other investors included Two Sigma Ventures, among others, and participation from seed investors Sherpa Healthcare Partners and Freeflow Ventures. ....

University Of Southern California , United States , Los Angeles , Lili Yang , Edmund Kim , Lyell Immunopharma , Mitchell Kronenberg , David Moskowitz , Jeff Wiezorek , Margo Roberts , Antoni Ribas , Appia Bio , David Baltimore , Francisco Gimenez , University Of California , Jonsson Comprehensive Cancer Center , California Institute Of Technology Caltech , Prnewswire Appia Bio Inc , Tumor Immunology Program , Jolla Institute For Immunology , Column Group , Two Sigma Ventures , Sherpa Healthcare Partners , California Institute , Scientific Advisory Board , Kite Pharma ,